Cargando…
Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer
PURPOSE: Uterine serous carcinoma (USC) is a rare but aggressive endometrial cancer histology. We reviewed outcomes for patients with USC to identify the best adjuvant treatment strategy. METHODS AND MATERIALS: We retrospectively identified 162 patients with The International Federation of Gynecolog...
Autores principales: | Arden, Jessica D., Marvin, Kimberly, Ye, Hong, Juratli, Lena, Nandalur, Sirisha R., Al-Wahab, Zaid, Field, Jayson, Gadzinski, Jill, Rakowski, Joseph Anthony, Rosen, Barry, Jawad, Maha Saada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718545/ https://www.ncbi.nlm.nih.gov/pubmed/33305084 http://dx.doi.org/10.1016/j.adro.2020.08.013 |
Ejemplares similares
-
Outcomes After Salvage Radiation Therapy for Recurrent Endometrial Cancer in Patients With No Prior Adjuvant Therapy: An Institutional Review
por: Arden, Jessica D., et al.
Publicado: (2020) -
Toxicity and Efficacy After Adjuvant Vaginal Brachytherapy Using 30 Gy in 6 Fractions for Stages I and II Endometrial Cancer
por: Arden, Jessica D., et al.
Publicado: (2021) -
Combined modality therapy in the adjuvant treatment of uterine serous carcinoma
por: Block, Alec M., et al.
Publicado: (2016) -
Evaluation of adjuvant therapy in women with uterine papillary serous cancer
por: Al Husaini, Hamed, et al.
Publicado: (2012) -
Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
por: Tate, Keisei, et al.
Publicado: (2018)